Pharma News 2_2
February 2, 2007 by Steve Woodruff
AstraZeneca projects slower growth, cutting thousands of jobs. However, increased spending on Crestor DTC advertising has led to a solid uptick in prescriptions.
Speaking of DTC advertising, might it be bad for your health?? (thanks for the tip, Adam!)
Some healthy results for companies with oncology portfolios – Roche and Celgene.
On the medical device front – an intriguing connection between stents and cognitive function.
But, Boston Scientific finds that the stent market has its own struggles.